Abstract
Immunohistochemical methods were used to search for Fas receptor/Fas ligand system involvement in multiple sclerosis (MS) white matter brain lesions. We found large numbers of Fas ligand (Fas-L)-bearing cells present in two acute lesions and 12 of 16 chronic MS lesions, and very few positive cells in non-inflammatory controls. Four of six brains from non-MS neuropathologic conditions associated with inflammation and white matter disease were, however, also positive for Fas-L. Double staining with cell-specific markers revealed that the pattern of ligand-positive cells in chronic MS lesions was complex and composed of several different cell types which were primarily resident glial cells with a small overlay of macrophages. Fas/APO 1 (CD95) receptor expression in MS tissue was also evaluated and marked upregulation of the receptor was found. In addition, Fas receptor was induced, but to a lesser extent, in numerous control brains. The observations that TUNEL-positive dying cells were present in MS lesions and showed excellent co-localization with Fas-L, indicate that the Fas death system may contribute to plaque pathogenesis and could lead to the development of a new category of therapeutic agents for MS.
MeSH Terms
Biological Specimen Banks
Brain/pathology
Cell Death
Fas Ligand Protein
Histocytochemistry/methods
Humans
Immunohistochemistry
Membrane Glycoproteins/isolation & purification
Multiple Sclerosis/etiology
Neuroglia/chemistry,pathology
Tissue Distribution
Up-Regulation
fas Receptor/isolation & purification
Chemicals
FASLG protein, human
Fas Ligand Protein
Membrane Glycoproteins
fas Receptor
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Dowling P
Neurology Service, Department of Veterans Affairs Medical Center, East Orange, New Jersey 07018, USA.
Shang G
Raval S
Menonna J
Cook S
Husar W
References (29)
29 references, click to expand
-
Fas ligand-induced apoptosis as a mechanism of immune privilege.
Science. 1995 Nov 17;270(5239):1189-92
PMID: 7502042
-
Immunologic mechanisms and therapy in multiple sclerosis.
Immunol Rev. 1995 Apr;144:75-107
PMID: 7590822
-
Fas antigen expression in brains of patients with Alzheimer-type dementia.
Brain Res. 1995 Oct 16;695(2):137-45
PMID: 8556323
-
Fas ligand in human serum.
Nat Med. 1996 Mar;2(3):317-22
PMID: 8612231
-
Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis.
Nature. 1996 Apr 25;380(6576):723-6
PMID: 8614469
-
Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice.
Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):574-8
PMID: 1370583
-
The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen.
J Immunol. 1992 Feb 15;148(4):1274-9
PMID: 1371136
-
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
Nature. 1992 Mar 26;356(6367):314-7
PMID: 1372394
-
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
J Cell Biol. 1992 Nov;119(3):493-501
PMID: 1400587
-
A novel domain within the 55 kd TNF receptor signals cell death.
Cell. 1993 Sep 10;74(5):845-53
PMID: 8397073
-
Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.
Lab Invest. 1993 Oct;69(4):415-29
PMID: 7693996
-
Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.
Cell. 1993 Dec 17;75(6):1169-78
PMID: 7505205
-
Pathogenesis of multiple sclerosis.
Lancet. 1994 Jan 29;343(8892):271-5
PMID: 7905102
-
Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium.
Int J Cancer. 1994 May 1;57(3):371-7
PMID: 8168998
-
Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils.
Blood. 1994 Aug 15;84(4):1201-8
PMID: 7519477
-
Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
J Clin Invest. 1994 Sep;94(3):954-64
PMID: 7521890
-
Role of Fas ligand in apoptosis induced by hepatitis C virus infection.
Biochem Biophys Res Commun. 1994 Oct 28;204(2):468-74
PMID: 7980502
-
Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.
Ann Neurol. 1995 Jan;37(1):82-8
PMID: 7818262
-
Fas antigen mRNA induction in postischemic murine brain.
Brain Res. 1994 Sep 19;657(1-2):342-6
PMID: 7529644
-
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
Nature. 1995 Feb 2;373(6513):438-41
PMID: 7530335
-
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.
Nature. 1995 Feb 2;373(6513):441-4
PMID: 7530336
-
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.
Nature. 1995 Feb 2;373(6513):444-8
PMID: 7530337
-
The Fas death factor.
Science. 1995 Mar 10;267(5203):1449-56
PMID: 7533326
-
Expression of the Fas ligand in cells of T cell lineage.
J Immunol. 1995 Apr 15;154(8):3806-13
PMID: 7706720
-
Expression of the functional soluble form of human fas ligand in activated lymphocytes.
EMBO J. 1995 Mar 15;14(6):1129-35
PMID: 7536672
-
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
Crit Rev Clin Lab Sci. 1995;32(2):121-82
PMID: 7598789
-
A role for CD95 ligand in preventing graft rejection.
Nature. 1995 Oct 19;377(6550):630-2
PMID: 7566174
-
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
J Exp Med. 1995 Nov 1;182(5):1223-30
PMID: 7595193
-
Expression of Fas/APO-1 during the progression of astrocytomas.
Cancer Res. 1995 Dec 1;55(23):5528-30
PMID: 7585627